| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Monday’s Close |
|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics, Inc. | $152.52 | $10.13B | N/A |
Sarepta Therapeutics (SRPT) Q4 2019 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2020/02/27/sarepta-therapeutics-srpt-q4-2019-earnings-call-tr.aspx?source=iedfolrf0000001
Feb 27, 2020 - SRPT earnings call for the period ending December 31, 2019.
0
Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram on Q4 2019 Results - Earnings Call Transcript
https://seekingalpha.com/article/4327626-sarepta-therapeutics-inc-srpt-ceo-douglas-ingram-on-q4-2019-results-earnings-call-transcript?source=feed_sector_transcripts
Feb 27, 2020 - Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2019 Results Earnings Conference Call February 26, 2020, 04:30 PM ET Company Participants Ian Estepan - Senior Vice President, Chief of Staff and Corporate
0
Sarepta Therapeutics (SRPT) Reports Q4 Loss, Tops Revenue Estimates
http://www.zacks.com/stock/news/785672/sarepta-therapeutics-srpt-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-785672
Feb 26, 2020 - Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of -72.68% and 0.02%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
0
Analysts Estimate Sarepta Therapeutics (SRPT) to Report a Decline in Earnings: What to Look Out for
http://www.zacks.com/stock/news/773612/analysts-estimate-sarepta-therapeutics-srpt-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-773612
Feb 19, 2020 - Sarepta Therapeutics (SRPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Roche (RHHBY) 2019 Sales Solid on Robust Show by New Drugs
http://www.zacks.com/stock/news/740314/roche-rhhby-2019-sales-solid-on-robust-show-by-new-drugs?cid=CS-ZC-FT-analyst_blog|earnings_article-740314
Jan 30, 2020 - Roche's (RHHBY) performance in 2019 is driven by solid strength in new drugs, which more than offset competition from biosimilars.
0
Are Options Traders Betting on a Big Move in Sarepta (SRPT) Stock?
http://www.zacks.com/stock/news/726416/are-options-traders-betting-on-a-big-move-in-sarepta-srpt-stock?cid=CS-ZC-FT-tale_of_the_tape|options-726416
Jan 20, 2020 - Investors need to pay close attention to Sarepta (SRPT) stock based on the movements in the options market lately.
0
Sarepta Therapeutics, Inc. (SRPT) Presents at JPMorgan Healthcare Broker Conference Call - (Transcript)
https://seekingalpha.com/article/4316634-sarepta-therapeutics-inc-srpt-presents-jpmorgan-healthcare-broker-conference-call-transcript?source=feed_sector_transcripts
Jan 14, 2020 - Sarepta Therapeutics, Inc. (NASDAQ:SRPT) JPMorgan Healthcare Conference Call January 13, 2019, 12:30 ET Company Participants Douglas Ingram - President, CEO & Director Gilmore O'Neill - EVP, R&
0
Applied Genetic Stock Up on Favorable Eye Therapy Study Data
http://www.zacks.com/stock/news/711529/applied-genetic-stock-up-on-favorable-eye-therapy-study-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-711529
Jan 10, 2020 - Applied Genetic's (AGTC) gene therapy candidate shows promise in an early-stage study to treat X-linked retinitis pigmentosa, a rare eye disorder.
0
Can Sarepta Therapeutics Stock Beat the Broader Markets in 2020?
https://www.fool.com/investing/2019/12/31/is-sarepta-therapeutics-stock-a-buy.aspx?source=iedfolrf0000001
Dec 31, 2019 - Wall Street has high hopes for this mid-cap biotech in the coming year.
0
Company News For Dec 24, 2019
http://www.zacks.com/stock/news/685690/company-news-for-dec-24-2019?cid=CS-ZC--corporate_summary-685690
Dec 24, 2019 - Companies in the news are: ACB, APA, ITCI, SRPT
0
Page 1>